Log in Free sign up

Bristol-Myers Squibb (BMY) Environmental, Social & Governance (ESG) Data

Employees

Data from SEC filings

Employee count

CEO pay ratio

CEO Salary

Median Employee Salary

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

Definitive proxy

Global Reporting Initiative (GRI)

Definitive proxy

Task Force on Climate-related Financial Disclosures (TCFD)

Definitive proxy

UN Sustainable Development Goals (SDGs)

Definitive proxy

ESG term mentions

In last year of SEC filings

Air Carbon Neutral Circular Clean Climate Climate Change Conservation Emission Environment Environmental Environmental Protection Intensity Landfill Life Cycle Materials Natural Resources Nature Net Zero Offset Package Packaging Pandemic Pollutant Pollution Raw Materials Renewable Resiliency Scarcity Science Based Targets Scope 1 Scope 2 Soil Waste Water Wind Access African American Asian Attrition Benefits Black Charitable Charity Community Culture Customer Cyber Cyber Security Cybersecurity D&I Data Privacy Data Security Death Demographics Disability Diversity Diversity and Inclusion Drug Pricing EEO-1 Employee Employee Engagement Engagement Ethnic Ethnicity Gender General Data Protection Regulation Health and Safety Health Care Healthcare Hire Hispanic Human Capital Human Resources Incident Inequality Injuries Injury LGBTQ Minority Opioid Parental Leave Pay for Performance Perquisites Privacy Product Quality Product Safety Recall Recruit Recruitment Reimbursement Resource Group Retention Retirement Safety Satisfaction Skill Skills Social Society Stakeholder Supplier Supplier Diversity Supply Chain Talent Training Union Volunteer Women Workers Workforce Anti-corruption Antitrust Assessment Assurance Attorney General Attorneys General Audit Board Effectiveness Board Evaluation Board Oversight Board Refreshment Bonus Bribery Chronic Class Action Lawsuit Classified Clawback Commitment Committee Evaluation Conflict of Interest Controversy Corporate Governance Corporate Purpose Corruption Department of ESG Ethics Executive Compensation Expert Fraud Goals Governance Hedging Incentive Incentivize Independence Independent Independent Chair Independent Lead Director Inequality Innovate Innovation Innovative Investigation Lawsuit Lead Independent Director Leadership Litigation Long-term Majority Mission Other Public Company Boards Oversee Oversight Perquisite Plaintiff Pledging Procurement Proxy Access Purpose Quality Standard R&D Recoup Reputation Reputational Reputational Risk Research and Development Responsibility Responsible Right to Call a Special Meeting Shareholder Engagement Shareholder Proposals Special Meeting Stewardship Strategy Sustainability Sustainable Targets Tax Tenure Transparency Transparent Voting Rights

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

BMY Bristol-Myers Squibb Co.

Letter to shareholders

BMY Bristol-Myers Squibb Co.

Letter to shareholders

BMY Bristol-Myers Squibb Co.

Letter to shareholders

Vote support at last AGM

(a)	The Annual Meeting of the Company was held on May 3, 2022.

(b)	Shareholders voted on the matters set forth below.